Published in Ochsner J on January 01, 2010
Recombinant Immunotoxin Therapy of Solid Tumors: Challenges and Strategies. J Basic Clin Med (2013) 0.78
Targeted therapy in rare cancers--adopting the orphans. Nat Rev Clin Oncol (2012) 0.77
Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations. Protein Sci (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68
Melanoma. N Engl J Med (2006) 8.80
Diphtheria toxin: mode of action and structure. Bacteriol Rev (1975) 7.47
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. J Clin Oncol (2009) 6.44
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84
Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J (1993) 4.35
Apoptosis and melanoma chemoresistance. Oncogene (2003) 3.58
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci U S A (1986) 3.41
Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell (1987) 2.93
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med (1997) 2.76
A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res (2004) 2.28
Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology (1997) 2.07
Cutaneous malignant melanoma in Europe. Eur J Cancer (2004) 1.88
Cutaneous malignant melanoma. Mayo Clin Proc (2006) 1.88
Immunotoxins for targeted cancer therapy. AAPS J (2006) 1.86
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. Crit Rev Immunol (2004) 1.68
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci U S A (2008) 1.66
Delivery of molecular medicine to solid tumors. Science (1996) 1.50
The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol (1991) 1.49
The capacity to retrieve escaped ER proteins extends to the trans-most cisterna of the Golgi stack. J Cell Biol (1995) 1.45
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. J Immunol (2006) 1.42
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol (1992) 1.39
Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J Biol Chem (1992) 1.38
Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proc Natl Acad Sci U S A (1999) 1.29
Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT. Br J Cancer (2010) 1.24
Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity. Proc Natl Acad Sci U S A (2000) 1.20
Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat Med (1996) 1.19
Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor. Biochem J (1995) 1.19
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma. Arch Dermatol Res (2000) 1.15
Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Int J Cancer (2004) 1.07
Systemic chemotherapy in the treatment of malignant melanoma. Expert Opin Pharmacother (2003) 1.05
Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery (1997) 0.95
Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. Trends Biotechnol (1998) 0.95
Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice. Cancer Res (1990) 0.94
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. Br J Cancer (2009) 0.92
Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer. Clin Cancer Res (1995) 0.92
The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. Exp Cell Res (2000) 0.91
Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment. Future Oncol (2009) 0.90
Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues. World J Gastroenterol (2005) 0.90
Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response. Oncology (2002) 0.88
Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel. PLoS One (2009) 0.87
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice. Bioconjug Chem (2007) 0.86
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. J Immunother (2010) 0.84
Targeted therapies in melanoma. Cancer Treat Rev (2006) 0.83
Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations. Int J Cancer (1992) 0.83
Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. J Immunol (1985) 0.82
Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity. Proc Natl Acad Sci U S A (1994) 0.82
Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs. Clin Cancer Res (1997) 0.81
The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. Int J Cancer (2009) 0.81
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells. Melanoma Res (2008) 0.80
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. Mol Cancer (2010) 0.80
Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens. J Cutan Pathol (1983) 0.80
A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck. Med Oncol (2008) 0.79
Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome. Clin Cancer Res (1995) 0.78
Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins. J Natl Cancer Inst (1986) 0.78
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics (2008) 3.11
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res (2006) 2.72
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells (2008) 1.70
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer (2004) 1.67
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One (2011) 1.49
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res (2007) 1.45
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Mol Oncol (2009) 1.37
Public health. Monitoring EU emerging infectious disease risk due to climate change. Science (2012) 1.37
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res (2004) 1.35
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res (2011) 1.35
Risk factors for domestic sporadic campylobacteriosis among young children in Sweden. Scand J Infect Dis (2005) 1.34
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res (2008) 1.33
Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res (2005) 1.32
The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroups. J Infect (2005) 1.32
Genetic diversity among food-borne and waterborne norovirus strains causing outbreaks in Sweden. J Clin Microbiol (2009) 1.29
Emerging genotype (GGIIb) of norovirus in drinking water, Sweden. Emerg Infect Dis (2003) 1.24
Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev (2009) 1.23
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS One (2013) 1.22
Outbreak of Salmonella Thompson infections linked to imported rucola lettuce. Foodborne Pathog Dis (2008) 1.20
GIS-supported investigation of human EHEC and cattle VTEC O157 infections in Sweden: geographical distribution, spatial variation and possible risk factors. Epidemiol Infect (2004) 1.19
Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res (2005) 1.15
Effect of regulation and education on reptile-associated salmonellosis. Emerg Infect Dis (2005) 1.13
Eye-opening approach to norovirus surveillance. Emerg Infect Dis (2010) 1.12
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer (2011) 1.12
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. Curr Cancer Drug Targets (2008) 1.11
Epigenetics in human melanoma. Cancer Control (2009) 1.09
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer (2013) 1.08
Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol (2004) 1.08
International outbreak of Salmonella Oranienburg due to German chocolate. BMC Infect Dis (2005) 1.07
Regional risks and seasonality in travel-associated campylobacteriosis. BMC Infect Dis (2004) 1.07
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets (2008) 1.07
Hepatitis A risk in travelers. J Travel Med (2009) 1.07
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun (2012) 1.06
Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res (2006) 1.06
Imported giardiasis: impact of international travel, immigration, and adoption. Am J Trop Med Hyg (2005) 1.06
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Clin Cancer Res (2009) 1.04
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther (2011) 1.03
Emerging metabolic targets in cancer therapy. Front Biosci (Landmark Ed) (2011) 1.02
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. Invest New Drugs (2010) 1.01
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. Int J Cancer (2012) 1.01
CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics (2008) 1.00
Could flies explain the elusive epidemiology of campylobacteriosis? BMC Infect Dis (2005) 1.00
Risk of travel-associated typhoid and paratyphoid fevers in various regions. J Travel Med (2005) 1.00
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. J Biol Chem (2012) 0.98
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis (2003) 0.98
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. J Gene Med (2007) 0.97
Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Mol Cancer Ther (2006) 0.97
Rac1 activity regulates proliferation of aggressive metastatic melanoma. Exp Cell Res (2007) 0.95
Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7). J Biol Chem (2013) 0.95
Com-1/p8 acts as a putative tumour suppressor in prostate cancer. Int J Mol Med (2006) 0.94
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma. PLoS One (2011) 0.92
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer? Int J Mol Med (2006) 0.92
B7-H3 and its relevance in cancer; immunological and non-immunological perspectives. Front Biosci (Elite Ed) (2011) 0.91
Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemics. J Clin Virol (2008) 0.91
Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Int J Cancer (2010) 0.90
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth. Cancer Immunol Immunother (2010) 0.90
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis (2007) 0.90
Fault tree analysis of the causes of waterborne outbreaks. J Water Health (2007) 0.90
Emergence of new Salmonella Enteritidis phage types in Europe? Surveillance of infections in returning travellers. BMC Med (2004) 0.89
Drinking water consumption patterns in Sweden. J Water Health (2006) 0.88
A food-borne streptococcal sore throat outbreak in a small community. Scand J Infect Dis (2006) 0.88
Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme. J Neurosurg (2004) 0.88
Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease. Eur J Haematol (2007) 0.88
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett (2012) 0.87
Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients. Lung Cancer (2008) 0.87
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology (2010) 0.87
Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals. Int J Cancer (2002) 0.85
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy. Cancer Gene Ther (2002) 0.85
Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res (2004) 0.85
EHEC O157 outbreak in Sweden from locally produced lettuce, August-September 2005. Euro Surveill (2005) 0.85
Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization? Radiother Oncol (2004) 0.85
Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem Biophys Res Commun (2002) 0.84
Public health burden due to infections by verocytotoxin-producing Escherichia coli (VTEC) and Campylobacter spp. as estimated by cost of illness and different approaches to model disability-adjusted life years. Scand J Public Health (2012) 0.84
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. J Immunother (2010) 0.84
Outbreak of norovirus in Västra Götaland associated with recreational activities at two lakes during August 2004. Scand J Infect Dis (2007) 0.83
Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med (2009) 0.83
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. Mol Cancer Ther (2005) 0.83
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma. Clin Exp Metastasis (2009) 0.83
Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status. Int J Cancer (2005) 0.83
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies. Int J Cancer (2013) 0.83
Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism. Cardiovasc Res (2003) 0.82
In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Exp Hematol Oncol (2013) 0.82
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. Cancer Gene Ther (2005) 0.82
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts. Cancer Genomics Proteomics (2008) 0.81
The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. Int J Cancer (2009) 0.81
Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner. Anticancer Res (2004) 0.79
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. Anticancer Res (2002) 0.79
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer. J Surg Oncol (2003) 0.79
Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. Biochem Biophys Res Commun (2005) 0.78
[Consequences of climate changes for the health status in Sweden. Heat waves and disease transmission most alarming]. Lakartidningen (2008) 0.78
The 14-3-3sigma gene promoter is methylated in both human melanocytes and melanoma. BMC Cancer (2009) 0.78
Structure of Ti2P solved by three-dimensional electron diffraction data collected with the precession technique and high-resolution electron microscopy. Acta Crystallogr A (2003) 0.78
Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins. J Immunother (2011) 0.78
The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells. J Ovarian Res (2014) 0.78
Detection of a previously uncommon salmonella phage in tourists returning from Europe. Lancet (2002) 0.78